|Videos|June 29, 2020

How Hospitals Can Replicate a COVID-19 Recovery Unit

Bradley Sherman, MD, shares insight as to what goes into a respiratory ventilator recovery unit.

Earlier this month, Northwell Health debuted a pair of specialized, acute ventilator recovery units (AVRU) at its Glen Cove Hospital and Northern Westchester Hospital in efforts to aid New York City-based patients with coronavirus 2019 (COVID-19) who are weaning off ventilator use.

The concept of these new units was to provide relief to the overburdened hospital staffs facing the brunt of the pandemic’s spread—as well as assist patients who have received tracheotomies while on ventilators and now require rehabilitation for severe muscle loss and physical weakness.

Combined, the hospitals have 17 beds in these new units designated to such patients, as the region has progressed to a phase of less strained and more informed emergency medicine practice during COVID-19.

In an interview with Contagion®, Bradley Sherman, MD, Medical Director and Chair of the Department of Medicine at Glen Cove Hospital, discussed how beneficial these units have proven, and how applicable they are to other hospitals now under a greater distress due to new and worsening COVID-19 cases.

“It’s a pretty labor-intensive staff unit, to really focus on aggressive weaning and physical therapy,” Sherman explained. “I do think for those people around the country who may be getting more of the wave as New York is coming down a little bit, I think there’s a need for these units, because it’s a way of decanting the ICUs.”


Related to this article

Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.